Non-interventional Study of Cabozantinib in Adults With Advanced Renal Cell Carcinoma
NCT ID: NCT03419572
Last Updated: 2022-08-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
689 participants
OBSERVATIONAL
2018-04-24
2022-05-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.
NCT03647878
A Non-interventional Retrospective Study to Describe Early Clinical Experience With Cabozantinib in Patients With Advanced Renal Cell Carcinoma (RCC) in the UK
NCT03696407
Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts.
NCT03744585
Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint Inhibitors
NCT03945773
Cabozantinib as Subsequent Therapy to an Immune Checkpoint Based Therapy in Renal Cell Carcinoma
NCT04714697
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Second line therapy
Data collection
Data collection
Only available evaluations as decided by the investigator based on local clinical practice will be collected.
Third and later line therapy
Data collection
Data collection
Only available evaluations as decided by the investigator based on local clinical practice will be collected.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data collection
Only available evaluations as decided by the investigator based on local clinical practice will be collected.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Has a diagnosis of advanced RCC
* Has received at least one prior VEGF-targeted therapy
* For whom the treating physician has decided to start treatment with cabozantinib tablets prior to inclusion
* No previous exposure to cabozantinib prior to inclusion
* Not concurrently involved in an interventional study
* Consents to participate in this noninterventional study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ipsen
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ipsen Medical Director
Role: STUDY_DIRECTOR
Ipsen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kepler University Hospital - Urology
Linz, , Austria
Universitatsklinikum fur Urologie und Andrologie
Salzburg, , Austria
Imelda Ziekenhuis
Bonheiden, , Belgium
Az Klina
Brasschaat, , Belgium
UZA
Edegem, , Belgium
Jessa Ziekenhuis
Hasselt, , Belgium
Az Damiaan
Ostend, , Belgium
Krajská Nemocnice Liberec, A.S., Komplexní Onkologické Centrum
Liberec, , Czechia
Fakultni Nemocnice Kralovske Vinohrady (FNKV) - Radioterapeuticka a Onkologicka klinika
Prague, , Czechia
Thomayerova Nemocnice, Onkologická Klinika 1. LF UK A TN
Prague, , Czechia
Fakultni Nemocnice na Bulovce, Institut of Radiation Oncology
Prague, , Czechia
CHU Angers
Angers, , France
CH Cote Basque
Bayonne, , France
Centre Hospitalier Universitaire
Besançon, , France
Hopital Saint Andre - CHU de Bordeaux
Bordeaux, , France
Centre Catalan d'Urologie
Cabestany, , France
Centre Maurice Tubiana
Caen, , France
CHU Henri Mondor
Créteil, , France
Grenoble University Hospital
Grenoble, , France
Polyclinique Chénieux
Limoges, , France
L'institut Mutualiste Montsouris
Paris, , France
Hospital De Cornouaille
Quimper, , France
Centre de Lutte Contre le Cancer (CLCC) - Institut Jean Godinot
Reims, , France
Institut de Cancérologie Lucien Neuwirth (ICLN)
Saint-Priest-en-Jarez, , France
Strasbourg Oncologie Liberale
Strasbourg, , France
Hôpitaux Universitaires de Strasbourg
Strasbourg, , France
CHU Tours - Hopital Bretonneau
Tours, , France
Vivantes Klinikum Neukolln
Berlin, , Germany
MVZ- Polyclinic Eisenach
Eisenach, , Germany
Universitaetsklinikum Frankfurt - Department of Urology
Frankfurt, , Germany
University Medical Center Halle (Saale)
Halle, , Germany
University Medical Center Hamburg-Eppendorf
Hamburg, , Germany
Asklepios Clinic Altona Hamburg
Hamburg, , Germany
University Medical Center LMU Munich - Campus Grosshadern, Urologische Klinik und Poliklinik Marchionnish R. 15
München, , Germany
Universitätsklinikum Münster
Münster, , Germany
MVP MP Saaletal Saalfeld/Saale
Saalfeld, , Germany
Dept of Urology, Eberhard-Karls-University Tuebingen
Tübingen, , Germany
University Medical Center Ulm
Ulm, , Germany
Evaggelismos Hospital
Athens, , Greece
Saint Savvas Hospital
Athens, , Greece
Alexandra Hospital
Athens, , Greece
G.O.H.K "Oi Agioi Anargiroi"
Athens, , Greece
Dep. Medical Oncology, University Hospital of Ioannina
Ioannina, , Greece
Papageorgiou Hospital
Thessaloniki, , Greece
Interbalkan Medical Center
Thessaloniki, , Greece
Azienda Ospedaliera S.Orsola Malpighi di Bologna
Bologna, , Italy
Fondazione IRCCS Istituto Nazionale Dei Tumori
Milan, , Italy
Azienda Ospedaliero Universitaria di Modena
Modena, , Italy
Aorn Cardarelli
Napoli, , Italy
National Cancer Institute "Fondazione G. Pascale" IRCCS
Napoli, , Italy
Umberto Basso
Padua, , Italy
Azienda Ospedaliero-Universitaria di Parma
Parma, , Italy
Fondazione Salvatore Maugeri - I.R.C.C.S
Pavia, , Italy
IRCCS Azienda Usl Di Reggio Emilia
Reggio Emilia, , Italy
Gemelli Hospital
Roma, , Italy
UOC Oncologia Azienda Ospedaliera Sant-Andrea
Rome, , Italy
Presidio Ospedaliero Santa Chiara
Trento, , Italy
Azienda Ospedaliera Universitaria Integrata Verona
Verona, , Italy
San Bortolo General Hospital
Vicenza, , Italy
Amphia Ziekenhuis
Breda, , Netherlands
Deventer Hospital
Deventer, , Netherlands
Haaglanden Medical Centre
Leidschendam, , Netherlands
Franciscus Gasthuis Hospital
Rotterdam, , Netherlands
Onkology Center
Bydgoszcz, , Poland
Szpital Kliniczny Przemienienia Panskiego w Poznaniu
Poznan, , Poland
Magodent SP Z O.O.
Warsaw, , Poland
Wojskowy Instytut Medyczny, Klinika Onkologii
Warsaw, , Poland
Dolnoslaskie Centrum Onkologii
Wroclaw, , Poland
Hospital Vall de Hebron
Barcelona, , Spain
Hospital Clinic de Barcelona
Barcelona, , Spain
Hospital De La Santa Creu I Sant Pau
Barcelona, , Spain
Hospital Dr. Josep Trueta
Girona, , Spain
Hospital Universitario de León
León, , Spain
Hospital Universitario Lucus Augusti
Lugo, , Spain
Hospital Ramón y Cajal
Madrid, , Spain
Hospital 12 de Octubre
Madrid, , Spain
Hospital Virgen de la Victoria
Málaga, , Spain
Hospital Morales Meseguer
Murcia, , Spain
Hospital Universitario Central de Asturias (Huca)
Oviedo, , Spain
Hospital Universitario Son Espases
Palma de Mallorca, , Spain
Complejo Hospitalario De Navarra
Pamplona, , Spain
Hospital Universitari Parc Tauli
Sabadell, , Spain
Complejo Hospitalario Universitario de Compostela
Santiago de Compostela, , Spain
Hospital Álvaro Cunqueiro de Vigo
Vigo, , Spain
Hospital Clinico Lozano Blesa de Zaragoza
Zaragoza, , Spain
East Kent Hospitals University NHS Foundation Trust
Canterbury, , United Kingdom
Royal Derby Hospital
Derby, , United Kingdom
Freeman Hospital-Northern Centre For Cancer Care
Newcastle, , United Kingdom
Mount Vernon Cancer Centre - East and North Hertfordshire NHS Trust
Northwood, , United Kingdom
Rosemere Cancer Centre, Royal Preston Hospital
Preston, , United Kingdom
Frimley Health NHS Foundation Trust - Wezham Park and Heatherwood Hospitals
Slough, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EUPAS19464
Identifier Type: REGISTRY
Identifier Source: secondary_id
F-FR-60000-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.